Cognitive dysfunction in cirrhosis is associated with falls: A prospective study

Hepatology

Volumn 55, Issue 6, 2012, Pages 1922-1930

  Soriano, Germán ^a,b,c   Román, Eva ^a,b   Córdoba, Joan ^b,c   Torrens, Maria ^d   Poca, Maria ^a   Torras, Xavier ^a,c   Villanueva, Càndid ^a,b,c   Gich, Ignasi J ^a   Vargas, Víctor ^b,c,d   Guarner, Carlos ^a,b,c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HEMOGLOBIN; SEDATIVE AGENT; SODIUM;

ADULT; AGED; ARTICLE; ASCITES; BODY MASS; BRAIN DISEASE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; CONTUSION; DECOMPENSATED LIVER CIRRHOSIS; DIABETES MELLITUS; EMERGENCY CARE; FALLING; FEMALE; FOLLOW UP; FRACTURE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEUROPSYCHOLOGICAL TEST; ORTHOSTATIC HYPOTENSION; OUTPATIENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE; PSYCHOMETRY; SCORING SYSTEM; SODIUM BLOOD LEVEL; VISUAL DISORDER; WOUND;

ACCIDENTAL FALLS; AGED; COGNITION DISORDERS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHOMETRICS;

EID: 84861572871     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25554     Document Type: Article

References (50)

1. Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance, and recommendations. J Hepatol 2005; 42: S45-S53.
2. Romero-Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. HEPATOLOGY 2007; 45: 879-885.
3. Bajaj JS. Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008; 14: 3609-3615.
4. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-773.
5. Córdoba J. New assessment of hepatic encephalopathy. J Hepatol 2011; 54: 1030-1040.
6. Schiff S, Vallesi A, Mapelli D, Orsato R, Pellegrini A, Umiltà C, et al. Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study. Metab Brain Dis 2005; 20: 381-392.
7. Bajaj JS, Córdoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, Morgan MY. Review article: the design of clinical trials in hepatic encephalopathy-an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 2011; 33: 739-747.
8. Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 2010; 55: 2381-2390.
9. Les I, Doval E, Flavià M, Jacas C, Cárdenas G, Esteban R, et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol 2010; 22: 221-227.
10. Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007; 102: 1903-1909.
11. Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR, et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. HEPATOLOGY 2009; 50: 1175-1183.
12. Román E, Córdoba J, Torrens M, Torras X, Villanueva C, Vargas V, et al. Minimal hepatic encephalopathy is associated with falls. Am J Gastroenterol 2011; 106: 476-482.
13. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990; 31: 82-87.
14. Collier J. Bone disorders in chronic liver disease. HEPATOLOGY 2007; 46: 1271-1278.
15. Cohen SM, Te HS, Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty 2005; 20: 460-466.
16. Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics 2010; 28: 395-409.
17. Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 2008; 101: 583-588.
18. Peeters G, van Schoor NM, Lips P. Fall risk: the clinical relevance of falls and how to integrate fall risk with fracture risk. Best Pract Res Clin Rheumatol 2009; 23: 797-804.
19. Kerse N, Flicker L, Pfaff JJ, Draper B, Lautenschlager NT, Sim M. Falls, depression, and antidepressants in later life: a large primary care appraisal. PLoS One 2008; 3: e2423.
20. Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med 1992; 117: 1003-1009.
21. Harwood RH. Visual problems and falls. Age Ageing 2001; 30 (Suppl 4): 13-18.
22. Romero-Gómez M, Córdoba J, Jover R, del Olmo J, Fernández A, Flavià M; Red Nacional de Investigación de Encefalopatía Hepática. [Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy]. [Article in Spanish] Med Clin (Barc) 2006; 127: 246-249.
23. Hauer K, Lamb SE, Jorstad EC, Todd C, Becker C. Systematic review of definitions and methods of measuring falls in randomised controlled fall prevention trials. Age Ageing 2006; 35: 5-10.
24. Harwood RH, Sahota O, Gaynor K, Masud T, Hosking DJ. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Ageing 2004; 33: 45-51.
25. Armstrong AL, Oborne J, Coupland CA, Macpherson MB, Bassey EJ, Wallace WA. Effects of hormone replacement therapy on muscle performance and balance in post-menopausal women. Clin Sci 1996; 91: 685-690.
26. World Health Organization. Falls. Violence and injury prevention and disability department. Available at:. Accessed on March 20, 2008.
27. Fischer ID, Krauss MJ, Dunagan WC, Birge S, Hitcho E, Johnson S, et al. Patterns and predictors of inpatient falls and fall-related injuries in a large academic hospital. Infect Control Hosp Epidemiol 2005; 26: 822-827.
28. Gates S, Fisher JD, Cooke MW, Carter YH, Lamb SE. Multifactorial assessment and targeted intervention for preventing falls and injuries among older people in community and emergency care settings: systematic review and meta-analysis. BMJ 2008; 336: 130-133.
29. Viccaro LJ, Perera S, Studenski SA. Is timed up and go better than gait speed in predicting health, function, and falls in older adults? J Am Geriatr Soc 2011; 59: 887-892.
30. Medow MS, Stewart JM, Sanyal S, Mumtaz A, Sica D, Frishman NH. Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope. Cardiol Rev 2008; 16: 4-20.
31. Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. HEPATOLOGY 1996; 24: 556-560.
32. Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol 2000; 32: 748-753.
33. Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010; 138: 2332-2340.
34. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. HEPATOLOGY 2002; 35: 357-366.
35. Amodio P, Del Piccolo F, Pettenò E, Mapelli D, Angeli P, Iemmolo R, et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 2001; 35: 37-45.
36. Lozeva V, Montgomery JA, Tuomisto L, Rocheleau B, Pannunzio M, Huet PM, et al. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. J Hepatol 2004; 40: 742-748.
37. Schlatter C, Egger SS, Tchambaz L, Krähenbühl S. Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation. Drug Saf 2009; 32: 561-578.
38. Stevens JA, Sogolow ED. Gender differences for non-fatal unintentional fall related injuries among older adults. Inj Prev 2005; 11: 115-119.
39. Schultz AB, Ashton-Miller JA, Alexander NB. What leads to age and gender differences in balance maintenance and recovery? Muscle Nerve Suppl 1997; 5: S60-S64.
40. Jorgensen L, Engstad T, Jacobsen BK. Higher incidence of falls in long-term stroke survivors than in population controls: depressive symptoms predict falls after stroke. Stroke 2002; 33: 542-547.
41. Jover R, Compañy L, Gutiérrez A, Lorente M, Zapater P, Poveda MJ, et al. Clinical significance of extrapyramidal signs in patients with cirrhosis. J Hepatol 2005; 42: 659-665.
42. Burkhard PR, Delavelle J, Du Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 2003; 60: 521-528.
43. Mak MK, Pang MY. Balance confidence and functional mobility are independently associated with falls in people with Parkinson's disease. J Neurol 2009; 256: 742-749.
44. Moreland JD, Richardson JA, Goldsmith CH, Clase CM. Muscle weakness and falls in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2004; 52: 1121-1129.
45. Córdoba J, Flavià M, Jacas C, Sauleda S, Esteban JI, Vargas V, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003; 39: 231-238.
46. Frith J, Kerr S, Robinson L, Elliott C, Ghazala C, Wilton K, et al. Primary biliary cirrhosis is associated with falls and significant fall related injury. QJM 2010; 103: 153-161.
47. Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA, et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011; 140: 478-487.
48. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. HEPATOLOGY 2007; 45: 549-559.
49. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. HEPATOLOGY 2004; 39: 1441-1449.
50. Michael YL, Whitlock EP, Lin JS, Fu R, O'Connor EA, Gold R. Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2010; 153: 815-825.